{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:36:08Z","timestamp":1786736168262,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijc.ijc_524_17","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T03:07:08Z","timestamp":1560222428000},"page":"288","source":"Crossref","is-referenced-by-count":0,"title":["Metastatic thymic epithelial tumors: A regional cancer center experience"],"prefix":"10.4103","volume":"55","author":[{"given":"Tamojit","family":"Chaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KC","family":"Lakshmaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GovindK","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokanatha","family":"Dasappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LinuAbraham","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC Suresh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AH","family":"Rudresha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KN","family":"Lokesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LK","family":"Rajeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.250891-1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1378\/chest.112.2.511","article-title":"Primary mediastinal tumors.Part 1: Tumors of the anterior mediastinum","author":"Strollo","year":"1997","journal-title":"Chest"},{"key":"key-10.4103\/0019-509X.250891-2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thorsurg.2010.08.001","article-title":"Management of stage I and II thymoma","author":"Detterbeck","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"key-10.4103\/0019-509X.250891-3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0019-509X.250891-4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","article-title":"Thymic carcinoma: A cohort study of patients from the European Society of Thoracic Surgeons Database","author":"Ruffini","year":"2014","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0019-509X.250891-5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 World Health Organization classification of tumors of the thymus: Continuity and changes","author":"Marx","year":"2015","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0019-509X.250891-6","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: Clarification and definition of terms","author":"Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0019-509X.250891-7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma.A 13-year experience","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.250891-8","doi-asserted-by":"crossref","unstructured":"Loehrer PJ Sr., Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994;12:1164-8.","DOI":"10.1200\/JCO.1994.12.6.1164"},{"key":"key-10.4103\/0019-509X.250891-9","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/1097-0142(19901115)66:10<2092::AID-CNCR2820661008>3.0.CO;2-1","article-title":"Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy","author":"Carlson","year":"1990","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.250891-10","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1097\/JTO.0b013e3181f21129","article-title":"The role of chemotherapy in advanced thymoma","author":"Schmitt","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0019-509X.250891-11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","author":"Yoh","year":"2003","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.250891-12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lungcan.2007.05.016","article-title":"Multimodal treatment of thymic carcinoma: Report of nine cases","author":"Magois","year":"2008","journal-title":"Lung Cancer"},{"key":"key-10.4103\/0019-509X.250891-13","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0019-509X.250891-14","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1097\/JTO.0b013e31822e71c0","article-title":"Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma","author":"Agatsuma","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0019-509X.250891-15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2009.03.031","article-title":"Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma","author":"Igawa","year":"2010","journal-title":"Lung Cancer"},{"key":"key-10.4103\/0019-509X.250891-16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lungcan.2011.05.013","article-title":"Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: Evaluation of efficacy and toxicity","author":"Okuma","year":"2011","journal-title":"Lung Cancer"},{"key":"key-10.4103\/0019-509X.250891-17","first-page":"109","article-title":"Thymoma:First large Indian experience","author":"Rathod","year":"2014","journal-title":"Indian J Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0019-509X","issn-type":"print"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:38:17Z","timestamp":1786732697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_524_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["250891"],"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_524_17","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}